Ischemic tolerance human marrow mesenchymal stem cell therapy(Jiuzhitang Maker)

缺血耐受人骨髓间充质干细胞疗法（九芝堂美科）

Report date: 2026/05/25 20:02:40

Base Information

Drug NameIschemic tolerance human marrow mesenchymal stem cell therapy(Jiuzhitang Maker)
Drug Alias Nameit-hMSC(Jiuzhitang Maker)Ischemic tolerance human allogeneic bone marrow mesenchymal stem cell therapy(Jiuzhitang Maker)
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeStrokeBrain Ischemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiuzhitang Maker (Beijing) Cell Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiuzhitang Maker (Beijing) Cell Technology Co LtdStemedica Cell Technologies Inc
Inactive CompaniesN/A
Active IndicationsStrokeBrain IschemiaPulmonary Alveolar Proteinosis
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeN/A
Related LinksN/A